Quarterly Financial Information [Table Text Block] |
|
|
Three months ended |
|
|
|
|
|
|
|
March 31, 2020 |
|
|
June 30, 2020 |
|
|
September 30, 2020 |
|
|
December 31, 2020 |
|
|
Total for year 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales |
|
$ |
18 |
|
|
$ |
— |
|
|
$ |
90 |
|
|
|
— |
|
|
$ |
108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating cost and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product sales |
|
|
1,454 |
|
|
|
1,306 |
|
|
|
1,635 |
|
|
|
1,081 |
|
|
|
5,476 |
|
Research and development cost |
|
|
242 |
|
|
|
217 |
|
|
|
210 |
|
|
|
358 |
|
|
|
1,027 |
|
General and administrative expense |
|
|
2,385 |
|
|
|
2,245 |
|
|
|
1,656 |
|
|
|
2,712 |
|
|
|
8,998 |
|
Total operating expenses |
|
|
4,081 |
|
|
|
3,768 |
|
|
|
3,501 |
|
|
|
4,151 |
|
|
|
15,501 |
|
Loss from operations |
|
|
(4,063 |
) |
|
|
(3,768 |
) |
|
|
(3,411 |
) |
|
|
(4,151 |
) |
|
|
(15,393 |
) |
Other income and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance proceeds net of related expenses |
|
|
(203 |
) |
|
|
(52 |
) |
|
|
1,722 |
|
|
|
1,479 |
|
|
|
2,946 |
|
Impairment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(11,741 |
) |
|
|
(11,741 |
) |
Interest expense |
|
|
(183 |
) |
|
|
(164 |
) |
|
|
(166 |
) |
|
|
(1,107 |
) |
|
|
(1,620 |
) |
Interest and other income |
|
|
22 |
|
|
|
3 |
|
|
|
18 |
|
|
|
5 |
|
|
|
48 |
|
Total other expense, net |
|
|
(364 |
) |
|
|
(213 |
) |
|
|
1,574 |
|
|
|
(11,364 |
) |
|
|
(10,367 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income tax expense |
|
|
(4,427 |
) |
|
|
(3,981 |
) |
|
|
(1,837 |
) |
|
|
(15,515 |
) |
|
|
(25,760 |
) |
Income tax expense |
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
Net loss |
|
$ |
(4,427 |
) |
|
$ |
(3,983 |
) |
|
$ |
(1,837 |
) |
|
$ |
(15,515 |
) |
|
$ |
(25,762 |
) |
Weighted average shares outstanding, basic and diluted |
|
|
59,582,603 |
|
|
|
60,136,374 |
|
|
|
60,998,971 |
|
|
|
62,136,421 |
|
|
|
60,861,450 |
|
Basic and diluted net loss per share |
|
$ |
(0.07 |
) |
|
$ |
(0.07 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.25 |
) |
|
$ |
(0.42 |
) |
|
|
Three months ended |
|
|
|
|
|
|
|
March 31, 2019 |
|
|
June 30, 2019 |
|
|
September 30, 2019 |
|
|
December 31, 2019 |
|
|
Total for year 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales |
|
$ |
437 |
|
|
$ |
1,483 |
|
|
$ |
2,361 |
|
|
$ |
593 |
|
|
$ |
4,874 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating cost and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product sales |
|
|
4,681 |
|
|
|
7,185 |
|
|
|
8,231 |
|
|
|
4,702 |
|
|
|
24,799 |
|
Research and development cost |
|
|
620 |
|
|
|
338 |
|
|
|
282 |
|
|
|
315 |
|
|
|
1,555 |
|
General and administrative expense |
|
|
4,016 |
|
|
|
4,335 |
|
|
|
5,107 |
|
|
|
5,856 |
|
|
|
19,314 |
|
Total operating expenses |
|
|
9,317 |
|
|
|
11,858 |
|
|
|
13,620 |
|
|
|
10,873 |
|
|
|
45,668 |
|
Loss from operations |
|
|
(8,880 |
) |
|
|
(10,375 |
) |
|
|
(11,259 |
) |
|
|
(10,280 |
) |
|
|
(40,794 |
) |
Other income and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance proceeds net of related expenses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(792 |
) |
|
|
(792 |
) |
Interest expense |
|
|
(2,889 |
) |
|
|
(203 |
) |
|
|
(142 |
) |
|
|
(243 |
) |
|
|
(3,477 |
) |
Interest and other income |
|
|
63 |
|
|
|
77 |
|
|
|
85 |
|
|
|
45 |
|
|
|
270 |
|
Total other expense, net |
|
|
(2,826 |
) |
|
|
(126 |
) |
|
|
(57 |
) |
|
|
(990 |
) |
|
|
(3,999 |
) |
Loss before income tax expense |
|
|
(11,706 |
) |
|
|
(10,501 |
) |
|
|
(11,316 |
) |
|
|
(11,270 |
) |
|
|
(44,793 |
) |
Income tax expense |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
Net loss |
|
$ |
(11,708 |
) |
|
$ |
(10,501 |
) |
|
$ |
(11,316 |
) |
|
$ |
(11,270 |
) |
|
$ |
(44,795 |
) |
Weighted average shares outstanding, basic and diluted |
|
|
43,514,225 |
|
|
|
50,757,448 |
|
|
|
57,053,982 |
|
|
|
57,523,283 |
|
|
|
52,263,885 |
|
Basic and diluted net loss per share |
|
$ |
(0.27 |
) |
|
$ |
(0.21 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.86 |
) |
|